JANSSEN SCIENCES IRELAND UNLIMITED COMPANY

Janssen Sciences Ireland Unlimited Company, operating as Johnson & Johnson Innovative Medicine Ireland, is a science-driven organisation dedicated to shaping the future of health. By listening to patients worldwide, the company translates real-life experiences into purpose-led innovations that aim to improve individual health outcomes, boost health-system productivity and enhance population health for today and tomorrow.

The firm's portfolio spans five core therapeutic focus areas - oncology, immunology, neuroscience, cardiopulmonary medicine and communicable diseases - delivering transformational treatments that can change and save lives. Janssen places a strong emphasis on collaboration, working alongside external partners across the Johnson & Johnson network as well as patient-advocacy groups to ensure that new solutions meet the needs of patients, clinicians and health-care systems alike.

Through its commitment to sustainable, science-based innovation, Janssen Sciences Ireland strives to be a catalyst for breakthrough medicines and a trusted partner in the global effort to advance health outcomes.